Atara Biotherapeutics, Inc. Business Operations Contracts & Agreements
24 Contracts & Agreements
- Collaboration Agreements (4 contracts)
- Development Agreements (5)
- Indemnification Agreements (1)
- Sales Agreements (5)
- Services Agreements (8)
- Termination Agreements (1)
- Amendment No. 8 to Commercial Manufacturing Services Agreement between Atara Biotherapeutics, Inc. and Charles River Laboratories, Inc. dated March 31, 2024 (Filed With SEC on May 9, 2024)
- Amendment No. 7 to Commercial Manufacturing Services Agreement between Atara Biotherapeutics, Inc. and Charles River Laboratories, Inc. dated January 31, 2024 (Filed With SEC on March 28, 2024)
- Amendment No. 6 to Commercial Manufacturing Services Agreement between Atara Biotherapeutics, Inc. and Charles River Laboratories, Inc. dated December 30, 2023 (Filed With SEC on March 28, 2024)
- Sales Agreement, dated November 1, 2023, by and between Atara Biotherapeutics, Inc. and Cowen and Company, LLC (Filed With SEC on November 1, 2023)
- Amendment No. 5 to Commercial Manufacturing Services Agreement between Atara Biotherapeutics, Inc. and Charles River Laboratories, Inc. dated September 27, 2023 (Filed With SEC on November 1, 2023)
- Termination, Amendment and Program Transfer Agreement dated August 2, 2022, by and between Atara Biotherapeutics, Inc., and Bayer AG (Filed With SEC on November 8, 2022)
- Amendment No. 3 to Commercial Manufacturing Services Agreement dated as of August 1, 2022 by and between Atara Biotherapeutics, Inc. and Charles River Laboratories, Inc (Filed With SEC on November 8, 2022)
- Amendment No. 2 to Commercial Manufacturing Services Agreement dated as of May 31, 2022 by and between Atara Biotherapeutics, Inc. and Charles River Laboratories, Inc (Filed With SEC on August 8, 2022)
- Fourth Amended and Restated Research and Development Collaboration Agreement between Atara Biotherapeutics, Inc. and the Counsel of the Queensland Institute of Medical Research,... (Filed With SEC on February 28, 2022)
- Sales Agreement, dated November 26, 2021, by and between Atara Biotherapeutics, Inc. and Cowen and Company, LLC (Filed With SEC on November 26, 2021)
- Amendment No. 1 to Commercial Manufacturing Services Agreement between Atara Biotherapeutics, Inc., and Cognate BioServices Inc., dated September 1, 2021 (Filed With SEC on November 4, 2021)
- Third Amended and Restated Research and Development Collaboration Agreement, by and between Atara Biotherapeutics, Inc. and the Counsel of the Queensland Institute of Medical... (Filed With SEC on November 9, 2020)
- Commercial Manufacturing Services Agreement, by and between Atara Biotherapeutics, Inc. and Cognate BioServices, Inc., dated December 24, 2019 (Filed With SEC on February 27, 2020)
- Amendment No. 5 to the Development and Manufacturing Services Agreement, by and between Atara Biotherapeutics, Inc. and Cognate BioServices, Inc., dated November 27, 2019 (Filed With SEC on February 27, 2020)
- Amendment No. 4 to the Development and Manufacturing Services Agreement, by and between Atara Biotherapeutics, Inc. and Cognate BioServices, Inc., dated November 4, 2019 (Filed With SEC on February 27, 2020)
- Sales Agreement, dated February 27, 2020, by and between Atara Biotherapeutics, Inc. and Cowen and Company, LLC (Filed With SEC on February 27, 2020)
- Amendment No. 3 to the Development and Manufacturing Services Agreement, by and between Atara Biotherapeutics, Inc. and Cognate BioServices, Inc., dated June 28, 2019 (Filed With SEC on November 7, 2019)
- Amended and Restated Amendment No. 2 to the Development and Manufacturing Services Agreement, by and between Atara Biotherapeutics, Inc. and Cognate BioServices, Inc., dated... (Filed With SEC on November 7, 2019)
- Second Amended and Restated Research and Development Collaboration Agreement, by and between Atara Biotherapeutics, Inc. and the Counsel of the Queensland Institute of Medical... (Filed With SEC on November 7, 2019)
- Sales Agreement, dated February 26, 2019, by and between Atara Biotherapeutics, Inc. and Cowen and Company, LLC (Filed With SEC on February 26, 2019)
- Development and Manufacturing Services Agreement, by and between Atara Biotherapeutics, Inc. and Cognate Bioservices, Inc., dated August 2015, as amended (Filed With SEC on August 1, 2018)
- Amended and Restated Research and Development Collaboration Agreement, by and between Atara Biotherapeutics, Inc. and the Council of the Queensland Institute of Medical Research,... (Filed With SEC on August 1, 2018)
- ATARA BIOTHERAPEUTICS, INC. $75,000,000 COMMONSTOCK SALES AGREEMENT (Filed With SEC on March 27, 2017)
- ATARA BIOTHERAPEUTICS, INC. INDEMNIFICATION AGREEMENT (Filed With SEC on June 20, 2014)
